Company Filing History:
Years Active: 2003
Title: Danna Lynn Skea: Innovator in T Cell Production
Introduction
Danna Lynn Skea is a notable inventor based in Mississauga, Canada. She has made significant contributions to the field of immunology, particularly in the production of T cells. Her innovative methods have the potential to impact various therapeutic and commercial applications.
Latest Patents
Danna Lynn Skea holds a patent for "Methods for the production of TcRγδ T cells." This patent describes a method for obtaining and expanding TcRγδ T cells in culture. The process involves culturing cells from a sample containing TcRγδ T cells or their precursors in a first culture medium that includes a T cell mitogen and at least two cytokines. Following this, the cells are cultured in a second medium comprising at least two additional cytokines. The preferred method includes using interleukin-2 and interleukin-4 in both culture steps. The TcRγδ T cells produced can be utilized in various experimental and therapeutic contexts.
Career Highlights
Danna Lynn Skea is associated with Hemosol Inc., where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in medical therapies and research.
Collaborations
Danna collaborates with notable colleagues, including David N Bell and Phyllis Robin Hedge. These partnerships enhance her research efforts and contribute to the development of innovative solutions in the field.
Conclusion
Danna Lynn Skea's contributions to T cell production represent a significant advancement in immunology. Her patented methods and ongoing work at Hemosol Inc. highlight her role as a key innovator in this important area of research.